Skip to main content

and
  1. No Access

    Article

    Serum IgA as a Prognostic Beacon: Anticipating Systemic Therapy Efficacy in Metastatic Clear Cell Renal Cell Carcinoma

    Immunotherapy-tyrosine kinase inhibitor (IO-TKI) therapy has revolutionized the treatment landscape for metastatic clear cell renal cell carcinoma (mccRCC); however, the absence of effective biomarkers poses a...

    Hong-Lei Cui MD, Jie Wu MD, Gan Du MD, You-Yan Guan MD in Annals of Surgical Oncology (2024)

  2. No Access

    Article

    Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer

    Results of previous studies about the prognostic roles of histone H4 lysine 16 acetylation (H4K16ac) and histone H4 lysine 20 trimethylation (H4K20me3) in breast cancer were inconsistent. Cellular experiments ...

    Bo Wang, Meng Zhou, **ng-li Gan in International Journal of Clinical Oncology (2023)

  3. Article

    Open Access

    AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer

    The prognostic role of either forkhead box A1 (FOXA1) or anterior gradient 2 (AGR2) in breast cancer has been found separately. Considering that there were interplays between them depending on ER status, we ai...

    Meng Zhou, **ng-li Gan, Yue-xiang Ren, Qian-xin Chen, Yuan-zhong Yang in BMC Cancer (2023)

  4. Article

    Open Access

    Distribution and prognosis of uncommon metastases from non-small cell lung cancer

    According to the literature and our experience, the most common sites of non-small cell lung cancer (NSCLC) metastases include the brain, bone, liver, adrenal glands, contralateral lung and distant lymph nodes...

    Fei-Yu Niu, Qing Zhou, **-Ji Yang, Wen-Zhao Zhong, Zhi-Hong Chen, Wei Deng in BMC Cancer (2016)